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Abstract 
The Human Papilloma Virus (HPV) is the most common sexually transmitted infection (STI) 
and can cause cervical cancer. Two vaccines are available to protect against the most common 
strands of the virus. Vaccination programs differ across Europe but most neglect young adults, 
who are the group with the highest risk of contracting STIs. Our aim was to explore the views of 
young women about the HPV vaccine communication strategy from four European 
countriesScotland, Spain, Serbia, and Bulgaria. These countries are characterized by different 
cervical cancer prevalence and vaccine implementation policies. We conducted focus group 
discussions with young women (aged 18-26) with various vaccination histories in a purposive 
sample. We subjected the data to thematic analysis with the purpose of identifying themes 
related to communication about the HPV vaccine. We recorded the information sources 
mentioned by participants. Participants discussed numerous sources of vaccine-related 
information. They approached information critically rather than naively and questioned the 
sources’ trustworthiness and motives. Participants desired transparent information about the risks 
of the virus and the risks and benefits of the vaccine. These risks and benefits were 
individualized in view of personal and external factors. Particular aspects of the vaccine and the 
way information was communicated resulted in feelings of uncertainty. There were notable 
cross-cultural differences in experiences with HPV vaccine communication. Our results suggest 
that transparent risk communication about the HPV vaccine is valued by young women. In 
addition, both individual and culturally-dependent factors influenced experiences with, and 
preference for, information.  
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THE VIEWS OF YOUNG WOMEN ON HPV VACCINE COMMUNICATION IN FOUR 
EUROPEAN COUNTRIES. 
 
Effective risk communication is fundamental to improve health behavior in general [1, 2] 
and to prevent sexually transmitted infections (STIs) in particular. The Human Papillomavirus 
(HPV) is the most common STI and may cause a number of serious health conditions, including 
genital warts and cervical cancer [3]. Cervical cancer is among the most prevalent cancer types 
in women worldwide. In 2005, almost 260.000 women were estimated to have died of cervical 
cancer with 80% of the cases occurring in the developing world [4]. Since 2006, two brands of 
the HPV vaccine have been introduced to guard against those HPV strains responsible for 70% 
of cervical cancer cases [5]. The HPV vaccine is effective in preventing HPV infection and HPV 
related diseases in 90%–100% of cases [6]. It is well tolerated with mild side effects, which 
makes it one of the most efficacious vaccines available [7]. 
 The HPV vaccine is increasingly available in a number of countries across the world [8]. 
In Europe it has been introduced with different implementation policies ranging from school-
based mass immunization programs to on-demand delivery or private sector provision only. This 
has led to different uptake rates. For example, a school-based program in Scotland resulted in 
92% coverage, while free on-demand provision in Greece in only 9% coverage [5]. Overall most 
countries in North-Western and Central Europe have implemented some sort of organized 
vaccination program or campaign [7]. In contrast, vaccination efforts in some South-Eastern 
European countries are still developing despite the region’s higher burden of cervical cancer [9, 
10]. Generally, programs have focused on vaccinating preadolescent girls before the onset of 
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sexual activity. Although a few countries offer catch-up programs for women in their twenties, 
this age group has mostly been neglected by vaccine policies [7], possibly due to cost-
effectiveness [11]. However, vaccination of young women is generally recommended as young 
women can still benefit from the vaccine, even if they have been infected with HPV. Although 
HPV vaccination has no therapeutic efficacy in women who have already been infected, 
infection with one virus type does not impede vaccine-induced protection from another type [12].  
Few countries offer catch-up programs for women in their twenties, and even fewer provide full 
insurance coverage [7]. Most significantly, women in their twenties show the highest HPV 
infection prevalence, which makes vaccination particularly beneficial [13]. 
Besides organized vaccination efforts, public communication is essential for informed 
decision making. The introduction of a new vaccine is accompanied by the challenge of 
educating the target audience with clear information [14]. Next to implementation policies, 
communication source, content, and form of the information shapes beliefs and behavior related 
to the HPV vaccine [see also 15-17, 2]. Concerns about risks and side effects can decrease 
intentions to get vaccinated [18, 19]. Even though the vaccine is not reported to have severe side 
effects, concerns about its risks may potentially be fuelled by negative reports in the media [20]. 
Anti-vaccine activism on the Internet and social media that advances the view that 
pharmaceutical companies exert undue influence for their own benefit can further increase 
skepticism [21].  
Uncertainties are also increased by what is perceived by users as a lack of transparency in 
communication. Transparent communication may require complete, non-misleading, and factual 
information about the HPV vaccine and its associated risks in public media [22, 23]. A recent 
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analysis shows that health provider’s materials may require more accurate, complete, and 
consistent information [24]. Some information might intentionally be left out, as it is potentially 
controversial to talk about young girls’ sexuality [25]. A Canadian study, for example, found that 
around 20% of mothers assumed that HPV vaccination promoted promiscuity and were therefore 
less likely to get their daughters vaccinated [26]. This concern can be further fuelled by media 
coverage on the topic [27]. Even though this issue is expected to be less severe in more liberal 
societies (e.g., Denmark, [28]), health providers might still neglect the sexual nature of the 
transmission in the promotion of the vaccine [25]. Generally, there appears to be a need for 
improved information which includes not only transparent risk and benefit statistics [19] but 
which also addresses the socio-cultural aspects that might influence vaccination decision making.  
Scientific reasoning alone might not be sufficient to deal with anti-vaccination attitudes 
[21]. The success of health efforts like the HPV vaccine introduction may be influenced by a 
country’s unique history and culture and their implications for people’s trust in health care 
systems, physicians and pharmaceutical companies (e.g., [29, 30]). For example, physicians’ 
recommendations increased HPV vaccination rates among 19–26 years old women in Australia 
[31]. However, physicians’ recommendations might not be taken into account if there is mistrust 
towards physicians and the domestic health care system such as in Hungary [32].  
More understanding is needed of contextual aspects including historical experiences, religious or 
political affiliation, and socioeconomic status that play a central role in shaping public trust in 
vaccines [33]. It has become clear that a “one-size-fits-all-approach” to introduce a HPV 
program is problematic [21]. For example, the most prominent constructs used in health behavior 
models might not be universal and social context and cultural factors can influence health-
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protective behavior directly [34]. Hence, an approach which focuses exclusively on individual 
level factors like those of most health-behavior models (e.g., Health-Belief Model [34], Theory 
of Planned Behavior [36]), can be insufficient to understand vaccination behavior in general and 
experience with information in particular. Qualitative research approaches can help in addressing 
this issue. They allow a thorough analysis and exploration of health issues and are valuable 
because they can take into account individual views embedded in social and cultural 
surroundings [37]. The differences in the implementation strategies of the vaccine across Europe 
offers a rich environment to investigate the reception of risk communication and the influence of 
policy and culture on  individual decision making. 
Aim 
The aim of this paper is to explore young women’s experiences with risk information 
about HPV and the HPV vaccine. We explored how women evaluated the quantity and quality of 
HPV-related information and information sources they consulted, and how this information 
affected their decisions about the HPV vaccine.
1
 We focused on young women between the ages 
of 18 and 26 in four European countries: Scotland, Spain, Serbia, and Bulgaria. We chose this 
age group because women aged 18-26 are at high risk of contracting STIs and can benefit from 
vaccination. However, most HPV vaccination policies and campaigns target younger girls, 
thereby excluding this vulnerable age group. We chose these countries because they have 
                                                          
1
 A different analysis of the discussions related to broader policy and cultural issues covering 
knowledge, experiences with vaccination, and psychological and social implications of vaccination has 
been published elsewhere [38]. 
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different implementation policies, thereby offering a variety of information exposure and 
experiences with HPV information.  
Methods 
We chose qualitative methodology in order to provide a rich description of women’s 
experiences as embedded in their social, cultural, and personal context. We conducted focus 
group discussions with university educated women in Scotland, Spain, Serbia, and Bulgaria. 
These countries are characterized by different HPV vaccination strategies targeting adolescent 
girls. In particular, Scotland employs a national mass school-based program, Spain
2
 offers free 
on-demand provision, while Serbia and Bulgaria offered only private provision at the time of 
data collection [5, 9]. None of the countries had implemented a catch-up vaccination program or 
any opportunity for vaccine cost reimbursement for women aged 18-26 [7, 9]. As a 
reimbursement for participation, participants entered a raffle with a maximum prize of 30 GBP 
in Scotland, 30 EUR in Spain, 3000 RSD in Serbia, and 50 BGN in Bulgaria, respectively. Ethics 
approval was obtained from the Research Ethics and Governance Committee at the leading 
institution Edinburgh Napier University, as well as the respective institutions at the University of 
Granada, the Serbian Psychological Society, and Sofia University. 
Participants 
Participants were women between 18 and 26 years old. They were recruited through 
purposive and snowballing sampling via posters, e-mailing lists, and forums in the local 
universities. We attempted to include women with various experiences and vaccination histories, 
                                                          
2
 In Spain, delivery of the vaccine varies by region [7]. Data collection took place in Granada, Andalucia, 
which offers free on-demand provision. 
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ranging from being vaccinated in school in the past to never having heard of the HPV vaccine 
before. We conducted eleven focus group discussions with 54 young women in total. Table 1 
describes the demographic characteristics of the participants and their allocation among focus 
groups. All participants were university students, representing a mix of majors.  
Table 1. Participant demographic characteristics 
 
Scotland Spain Bulgaria Serbia Total 
Number of focus groups 3 3 3 2 11 
Number of participants 10 25 10 9 54 
Mean age 22.2 19.8 22.3 22.8 21.8 
Sexually active 9 19 10 8 46 
Vaccinated 4 3 0 0 7 
Had prior knowledge about HPV 
vaccine 
10 21 9 3 43 
Attitude towards the HPV vaccine 
   
  Interested 1 8 1 2 12 
Unsure 6 8 7 7 28 
Not interested 3 9 2 0 14 
 
 
Data collection 
The discussions were conducted between December 2011 and July 2012. The same 
procedure was followed in all four countries. All materials were translated into the local 
language. Participants were informed about the nature of the focus group discussion, signed an 
informed consent, and filled in an anonymous questionnaire with demographic information, 
sexual and vaccination history. All discussions lasted around one hour and were facilitated by 
two native speakers according to the same topic guide. The topics covered included participants’ 
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opinions and experiences with vaccination in general and the HPV virus and vaccine in 
particular, including sources of information about the HPV vaccine. Towards the end of the 
discussions participants were presented with a sample of publicly available brochures about the 
HPV vaccine. These always included a brochure from the respective country in the local 
language. Additionally, brochures from the participating countries as well as other European 
countries were available. As the latter were in a foreign language, they were provided simply for 
visual inspection. The purpose of presenting the brochures was to provide a further basis for 
discussion. Participants were given time to get acquainted with the materials and had the 
opportunity to comment. 
Analysis 
The discussions were digitally recorded and transcribed by native speakers of the local 
language. Personally identifying information was removed. The Spanish, Serbian and Bulgarian 
transcripts were translated into English by native speakers who were fluent in English. To ensure 
quality of the translation random subset back-translations were performed [39].  
Thematic analysis. The transcripts were subjected to thematic analysis following Braun 
and Clarke [39]. Thematic analysis is a method for identifying, analysing, and reporting 
recurring patterns (i.e., themes) within data. We adopted a mixture of inductive and theoretical 
approaches to our thematic analysis. In particular, we coded the data specifically for issues 
related to risk communication (as opposed to all interesting issues that might be present). 
However, we chose no particular theory or model against which to evaluate the data but 
preferred an exploratory approach. The topics we coded for included but were not limited to the 
following: (1) perceived risk of HPV and cervical cancer, (2) experience with, and perceived 
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quality, of risk information, (3) preferred information sources, (4) experience with, and perceived 
quality, of information sources, and (5) preferred/recommended  manner of risk communication.  
We followed the steps outlined by Braun and Clarke [40] while taking into account the cross-
cultural nature of our data. In particular, each coder (authors DP, AL, and RM) first familiarized 
herself with the data after receiving training in qualitative research. Then each transcript was 
coded for significant features by two coders. These initial codes were then organized into initial 
themes by each individual coder. Next, each coder was assigned a country for which she 
compared, summarized, and organized the initial themes into a thematic map first for each focus 
group separately and then for the respective country as a whole. The similarities and differences 
between the country’s thematic maps were organized into an overall thematic map for the whole 
data set following extensive discussion between all coders. The final thematic map was refined 
by the first author after “going back to the data” to check if the final themes fit in relation to the 
coded abstracts (e.g., identifying telling quotes to illustrate the themes).  
Information sources analysis. Participants discussed numerous sources of HPV-related 
information.  Hence, we decided to subject our qualitative data to quantitative analysis (e.g., see 
[41]) in order to give a more thorough overview of women’s experiences. We recorded the 
frequency with which participants mentioned 1) a unique information source from which they 
obtained information about the HPV vaccine
3
, and 2) a unique information source they would 
consult if they required such information. We grouped the sources into meaningful categories 
and computed the number of times a source from each category was mentioned in each 
discussion. 
                                                          
3
 No differentiation was made between instances in which the participant herself searched for information 
from a source or was approached by the information source as this was not specified on many occasions. 
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Results  
Thematic analysis 
We identified two main themes: Critical Appraisal of Information and Risk 
Adjustment (Table2). Critical Appraisal of Information encompassed two stages of obtaining 
HPV-related knowledge. The first stage of information reception was more passive: it reflected 
participants’ appraisals of the available information. Common subthemes were perceived lack of 
information and role of the media. The subtheme transparency marked the transition to a more 
active stage of knowledge acquisition: Participants evaluated the transparency of the 
communicated evidence and purposefully searched for what, in their perspective, was transparent 
and trustworthy information. Other common subthemes were active information search and 
information sources and reliability. The theme Risk Adjustment reflected the stage of decision 
making about the HPV vaccine. The subtheme my risk, my benefits captured how participants 
perceived and adjusted their risk of HPV and the benefit of the vaccine in view of a number of 
personal factors. Other subthemes were alternatives to vaccination and uncertainty, which 
reflected how risks and benefits regarding HPV and the vaccine were interpreted in view of 
contextual factors. These themes were common across the four countries. However, some of the 
themes were more prominent in certain countries than others. Below we clarify the themes in 
more detail and provide excerpts from the focus group discussions to illustrate the participants’ 
perspectives. 
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Table 2. Thematic framework developed from the analysis. 
Critical 
Appraisal 
Lack of information 
Role of the media 
Transparency 
Active search for information 
Information sources and 
reliability 
Risk 
Adjustment 
My risk, my benefit 
Alternatives to vaccination 
Uncertainty 
 
Critical Appraisal of Information  
 This theme illustrates participants’ overall critical approach towards the information they 
encountered. Most young women in this study felt insufficiently informed and desired 
transparent information about the risks and benefits of the virus and the vaccine. When assessing 
the credibility of information, they questioned the trustworthiness and motives of information 
providers. Sometimes this led them to feel supported, and sometimes misled or manipulated. 
 We don’t know: Lack of information. Participants’ knowledge about HPV ranged from 
little to more advanced knowledge. However, a common perception was that the obtained 
information was insufficient to make an informed decision about vaccination. This idea was 
shared both by participants who took part in a school vaccination campaign and participants who 
had barely heard of the HPV vaccine. Further, this perceived lack of information often translated 
into an inference that the vaccine was not very important. Some participants thought that if the 
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vaccine was indeed beneficial, then more information would have been distributed, reflecting the 
support of authorities for the vaccine.  
“And if the vaccine is still so important to cervical cancer, why aren’t they still giving 
information about it, so that more girls can get the jab? It was a craze that has stalled now.” 
(P5, FG2, Spain)
4
 
“Well, for me the primary reason is that, in reality, if the government wanted to support 
this thing, it would have provided more information, as a first step towards action.” (P1, FG1, 
Bulgaria) 
Young women presented themselves as part of an information generation with access to 
knowledge sources. Yet, this privilege stood in contrast to their lack of knowledge about HPV. 
This is illustrated by a participant from Serbia who reflected on the far greater information 
disadvantages experienced by people with fewer educational and socio-economic opportunities: 
“Well you [have us here] who are relatively educated and informed, who are following 
all sorts of things and then if we do not know ... Then I cannot imagine someone who does not 
have access to the internet and no access to television, how can someone know? But that's what 
we have here…” (P4, FG2, Serbia) 
You shouldn’t be advertising: The role of the media. Women often talked about the 
information they had obtained from the media such as television and newspapers. In particular, 
television advertisements were frequently discussed. Their strength was seen in sparking interest 
and raising awareness. In addition, women recognized that the media played a major role in how 
                                                          
4
 Quotes identifiers are (Participant number, Focus Group Number, Country). 
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information was dissipated, and “that the image of vaccines depends mostly on how the media 
plays it” (P5, FG1, Spain). As a consequence one needed to rely on one’s own active critical 
skills rather than be a passive recipient of advertising or news coverage. For example, the quote 
below illustrates how the information provided through advertising was seen as shallow and 
insufficient, which implied that one had to go beyond such superficial information  to be truly 
informed.  
“There was a lot of advertisements on TV, there was a craze, a lot of advertising on TV 
selling it but actually about information, they didn’t inform at all, [they told you] it just 
prevented the possibility of having cervical cancer but they didn’t tell you the cons or pros that 
the decision of getting the vaccine or not could have for you.” (P5, FG2, Spain) 
Often the media were seen as “selling” the vaccine rather than providing information 
about it and this had a negative connotation. This idea was reinforced by presenting the vaccine 
in absolutely positive terms and in a commercial context. A common perception was that 
important medicines like the HPV vaccine were potentially life-saving and should not be sold 
akin to a commercial product by using emotions or an attractive appearance.  
“I don’t think that the brochure must have a very attractive appearance, because its aim 
is not to sell a product, but mainly to inform.” (P1, FG1, Bulgaria) 
Participants often “saw through” the advertiser’s intentions or recognized their influential 
techniques, labelling them as “manipulative” or “directed”. The overall negative perception of 
the commercialized vaccine is illustrated by the following discussion of an advertisement among 
Scottish participants: 
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“P4: I think it was like “arm against cervical cancer” or something (voices overlapping: 
yeah)…I think that’s what it was called, there was a chain of girls holding arms and it was all 
sorts of girls you know… just all sorts of people you know (laughing)…and I think that was quite 
appealing to the age group. P3: I think it was quite directed…which then to me I think that’s 
wrong, you shouldn't be advertising, you know thinking about the audience like that because it’s 
not a product, it’s er.. medical, you’re not trying to sell this!” (FG2, Scotland)  
It’s here to convince: Transparency. Participants often commented that the information 
they encountered was unbalanced. What they meant was that it was presented purposefully in a 
biased fashion, or certain aspects were omitted, in order for the information to be more 
persuasive. Such information was evaluated unfavourably, while information which consisted of 
presenting both pros and cons was evaluated more favourably and as more trustworthy. Among 
the omissions mentioned were mainly the possible side effects of vaccination, or the fact that 
there are more strains of the virus than the vaccine protects you from. In that sense, presenting 
the vaccine as “100% protection” was seen as misleading.  
[Commenting on a brochure] “Also this one, it seems that it’s here to convince that it’s 
necessary to get the vaccine, let’s say. It should also say different points of view, the side effects 
and all that. I see that it mostly supports a position.” (P2, FG1, Spain) 
“I liked very much in that brochure that it said everything very realistically, and not to 
delude you, for example, that if you get vaccinated you will 100% be… It is directly described 
that they don’t guarantee.” (P3, FG2, Bulgaria) 
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When discussing what sort of information women wanted to receive about the virus and 
the vaccine again great emphasis was placed on transparency. This meant presenting facts in an 
open, unbiased fashion, as well as tailored to the needs of the recipients, such that it was 
understandable and adequate. For example, one woman expressed her desire to see more 
statistical information as opposed to persuasive appeals, or “fairy tales” as she referred to them 
with irony. 
“Scientific, statistics, something very exact which can answer your questions in a more 
detailed way, not like a fairytale. Because brochures are like fairytales. This is great, absolutely, 
you will reinvent the wheel if you get the vaccine.” (P3, FG3, Bulgaria) 
Find out for yourself: Active information search. Women’s perception was that they 
would not receive the necessary information about the vaccine unless they actively searched for 
it. Rather, they had to be pro-active and inform themselves.  
“I think that there is information if you look for it, you know, if you have gone to get 
some information. If you haven’t gone to get information, no...” (P2, FG1, Spain) 
Some of them reported “doing their own research” about the vaccine as the information 
they initially received was insufficient. On the one hand, it was perceived as routine to look for 
additional information, as not all the necessary knowledge could be conveyed in one source or be 
targeted to all sorts of recipients. However, some young women perceived that information was 
withheld, so that they would have to make an effort to get it. For example, one Bulgarian 
participant commented on her impression that Bulgarian doctors were reluctant to provide 
information unless you specifically asked about it:  
VIEWS OF YOUNG WOMEN ON HPV VACCINE COMMUNICATION                         18 
 
“Now, to be honest, doctors here are like that: unless you ask about every single detail 
that you are concerned about, they will not start explaining and give you the information you 
need. You have to ask and find out for yourself. So it is questionable how much doctors are 
informing us.” (P2, FG1, Bulgaria) 
We first investigate the doctor: Information sources and their reliability. Women 
discussed numerous sources of information, ranging from health professionals to people with 
experience with vaccination (see information sources analysis for further details). Among these, 
family and friends played a supportive rather than an informative role, except for when they were 
health professionals. Rumours and personal stories of people who got vaccinated were also 
pervasive, especially in the Spanish focus groups. Most significantly, gaining a second opinion 
was emphasised in the discussions. . In that sense, sources needed to be “triangulated” in order 
for the information to be verified. One example suggested by participants was searching for 
information on the Internet and then talking to one’s doctor.  
Most importantly, information was not assimilated blindly. Rather, participants would 
evaluate the source’s trustworthiness and motives before making a decision based on the 
provided information. This included seeking “expert” opinion from someone who was seen as 
competent rather than trusting random posts on the Internet. It was recognized that even expert 
sources could be biased for various reasons (e.g., doctors having a contract with pharmaceutical 
companies). This was particularly the case in Serbian and Bulgarian discussions where health 
professionals were often mistrusted. One solution to this problem was to consult a doctor who 
had a personal connection to the family. 
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“I rely mainly on the opinions of relatives and family friends who are doctors or of 
similar profession, what should and what should not be necessary, which are bad and good sides 
of the vaccine.” (P2, FG1, Serbia) 
“Well, we first investigate that doctor and see if he’s good. If he has a lot of patients...I, 
by the way, have investigated my personal gynaecologist through the Internet and I know that he 
is very good, so maybe I would trust him.” (P2, FG2, Bulgaria) 
Risk Adjustment 
 This theme captures how participants acted on the information they had obtained and 
approached the decision about HPV vaccination. Very prominent in this theme was the tendency 
for risks and benefits to be strongly individualized in view of personal, generational, and societal 
factors. Certain aspects of the vaccine and the available information resulted in feelings of 
uncertainty. The core issues in this theme were mostly similar across countries. However, some 
of them were manifested in different ways in the Western and Eastern discussions. We elaborate 
on these cross-cultural differences below.  
It depends: My risk, my benefits. When considering their decision regarding the HPV 
vaccine, women tended to talk about the risks of contracting HPV and the associated benefit of 
the vaccine in personal rather than in absolute terms. Risk perceptions were adjusted according 
to factors like age, sexual history and current relationship status. As women were mainly in their 
twenties, they considered the potential number of past sexual partners as indicative of the 
likelihood that they had already encountered the virus. This led to further discussions around 
doubts of the vaccine’s effectiveness for  their age group.  
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“Now I’m thinking well it’s quite useless cos I’ve already had some sexual partners and I 
could have it already and I think smear tests are useful for that reason.” (P1, FG1, Scotland) 
“Well, we are already sexually active, and you are supposed to get the vaccine before 
you become active, because then it is most….I forgot the word... most effective. Actually, at this 
point, you can’t be sure about the effectiveness of the vaccine.” (P2, FG1, Bulgaria) 
Young women also considered the number of potential future sexual partners as 
indicative of the risk group they belonged to. In that sense, having one stable partner was seen as 
a means of risk reduction which  rendered vaccination at that  point less beneficial. This is 
illustrated by one Serbian participant who was considering what she would have done if she were 
offered the vaccine. She considered HPV vaccination strictly as “a matter of choice” because not 
everyone was at the same risk of infection; risk was individualized and dependent on lifestyle: 
“First, you need to start with introducing some educational measures and then later to 
make it simple: a matter of choice. It depends on what kind of person you are. I do not know, 
maybe I wouldn’t have agreed, because I just know who I am, I do not let myself into 
relationships, how to put it... I do not have many partners.” (P3, FG1, Serbia) 
What’s the use of it? Alternatives to vaccination. Women discussed alternative ways of 
protection for themselves, for the female population and society in general. In Spain and 
Scotland these were most often cervical screening with smear-tests and regular visits to the 
gynaecologist. Questions were often raised about the relationship between screening and 
vaccination, as well as possible “removal” of the virus if discovered through screening. For 
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example, one Spanish participant thought that the vaccine was useless if one had regular check-
ups. 
“Screening is something that might be…even more effective, then if you keep track you’re 
going to avoid it and all that. Had I known it earlier, we would have saved a lot of money from 
vaccines [laughter]. If I’m going to have my check, what’s the use of it?” (P3, FG2, Spain) 
Sexual education and responsible sexual behaviour were seen as alternative means of 
protection for the young women themselves and for the population as a whole. This perspective 
was emphasized in Bulgaria and Serbia. Participants discussed ignorance about HPV and the 
HPV vaccine in the context of their societies: they identified the lack of sex education from an 
early age as the reason for the lack of awareness of sexually-transmitted infections. Education 
was seen as a way to promote responsible sexual behaviour, which in turn would reduce risks. 
However, for participants mass HPV vaccination was at an advanced stage of protection, which 
was still far away in view of the two countries’ lack of policies and lack of public awareness 
regarding STIs.  
The joint influence of personal and societal factors in considering the benefits of 
vaccination against other alternatives is illustrated by two Bulgarian women: 
“P1: [Reading off a brochure, turns to P3] Even if you get vaccinated, it is no guarantee 
and you have to continue with the screening. P3: Then what is the point of this vaccine? P1: So, 
450 + 75 leva
5
 every month... P3: This is meant for a country whose health system is waaay 
ahead of ours.” (FG3, Bulgaria) 
                                                          
5
 ~EUR265 
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We can’t know: Uncertainty. Women’s decisions regarding the vaccine were 
characterized by three dimensions of uncertainty. One concerned their personal judgment of the 
available information such as knowing whom to trust or what information is most important. 
This was very much related to the subtheme about information sources and their reliability, and 
its impact on decisions. The uncertainty relating to finding a competent and trustworthy 
information source is illustrated by a heated discussion among Spanish participants about the 
role of health professionals in providing information: 
“P5: Nowadays you go to the doctor, or to the pharmacist, asking them about the human 
papillomavirus or about the vaccine and for sure they still don’t know what to tell you. P3: And 
it’s not only that, because if you go to the doctor you go to a place where you feel safe. P4: 
That’s why I’m saying that I, if the doctor tells me about getting it and I get it because I trust him 
and that’s it, but if I, for example, am not really sure because I might think, why is it that they 
give it to a type of person and the other…? You know? I can ask myself a thousand questions, 
then if I’m interested, because it’s my health, I can also go to other, to other kind...P3: But it’s 
supposed that these questions should be answered by the doctor? P4: It’s supposed, you’ve said 
it yourself, it’s supposed! P5: Come on, if the doctor doesn’t answer them, where do you think 
you’d go?” (FG2, Spain) 
Another type of uncertainty referred to the vaccine’s side effects. In the Spanish and 
Scottish focus groups discussions of media reports about deaths or personal stories of people 
experiencing violent side effects were a frequent topic. While some participants disregarded 
these reports as “hyped up” or eventually discredited, for others they undermined the vaccine’s 
credibility or made them reconsider the vaccine’s benefits.  
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“I think that there are many side effects, which aren’t known. Only fever, dizziness, 
fainting are known. That there are a lot of others, that there are people who get paralysed or can 
even die and all that, and not a lot is known.” (P9, FG3, Spain) 
“I go for it, because...I didn’t know the risks with a vaccine. I wasn’t really aware of 
them, but I figured side effects I can put up with it if the rest is beneficial...”(P2, FG2, Scotland) 
Finally the vaccine’s novelty brought about feelings of uncertainty related to future 
consequences, especially among Western-European participants. Young women wanted vaccines 
that were 100% safe, well-tested, and approved. At the same time they recognized that the HPV 
vaccine had only been in use for a few years and that its long-term effects had not been 
established. On the one hand, this made some young women feel akin to “guinea pigs” and reject 
the vaccine.  On the other hand, it was recognized that one generation had to be the first to take 
the risk for the greater final good. Some participants were under the impression that even experts 
had doubts, and this contributed to their uncertainty: 
“But yeah it’s too new to say whether it is good or not. There should be further studies. 
The results of what is happening now should be released.”(P1, FG1, Scotland) 
“Yes, yes, they [HPV vaccines] are a part of the immunization schedule already, and I 
think it’s rushed, that they should have researched more. Knowing that it isn’t, that the vaccine 
isn’t developed, knowing that you don’t know what can happen when you get it, putting it up on 
the schedule… And there are many doctors, the medical opinion has been divided because of 
that, because it’s been a big debate, and I think it’s very important that the medical opinion has 
been divided.” (P5, FG1, Spain) 
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Information source analysis 
Participants brought up information sources on 134 occasions, with some participants discussing 
multiple sources and some discussing none. The information sources were grouped into 8 
categories (see Table 3).  
Table 3. Information sources, descriptions, and frequency with which they were discussed. 
Source Description Frequency Percent 
Health 
professionals 
Doctor, general practitioner, 
gynecologist, nurse, etc. 
40 29.9 
Internet 
"The internet", Google, forums, 
general search without 
specification 
25 18.7 
Media 
TV, news, newspapers, 
entertainment culture , TV 
commercials, advertisements 
21 15.6 
Family/friends 
Mothers, friends, acquaintances, 
etc. 
18 13.4 
Family/friends who 
are health 
professionals 
Mother who is a doctor, cousin 
who is a nurse, etc. 
12 9.0 
School 
"In school" in general, listened to 
a talk at school 
7 5.2 
Scientific sources Medical publications, scientists 7 5.2 
People with 
experience 
Vaccinated individuals, people 
who have decided about 
vaccination 
4 3.0 
Total   134 100.0 
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Table 4. The number of times women in each country discussed having obtained information from each information source.  
 
Bulgaria Scotland Serbia Spain All countries 
Source Count % Count % Count % Count % Count % 
Health professionals 2 15% 2 13% 3 38% 6 21% 13 20% 
Internet 2 15% 2 13% - - 1 3% 5 8% 
Media 5 38% 6 38% 2 25% 7 24% 20 30% 
Family/friends 4 31% 1 6% 1 13% 10 34% 16 24% 
Family/friends health  professionals - - 2 13% 1 13% 2 7% 5 8% 
School - - 2 13% 1 13% 3 10% 6 9% 
Scientific sources - - 1 6% - - - - 1 2% 
People with experience - - - - - - - - - - 
Total 13 100% 16 100% 8 100% 29 100% 66 100% 
  
Table 5. The number of times women in each country discussed that they would prefer to consult each information source.  
  Bulgaria Scotland Serbia Spain All countries 
Source Count % Count % Count % Count % Count % 
Health professionals 6 38% 4 29% 9 38% 8 57% 27 40% 
Internet 7 44% 5 36% 5 21% 3 21% 20 29% 
Media - - - - 1 4% - - 1 1% 
Family/friends 1 6% - - 1 4% - - 2 3% 
Family/friends health professionals - - 2 14% 5 21% - - 7 10% 
School - - - - - - 1 7% 1 1% 
Scientific sources 2 13% 3 21% 1 4% - - 6 9% 
People with experience - - - - 2 8% 2 14% 4 6% 
Total 16 100% 14 100% 24 100% 14 100% 68 100% 
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Table 4 shows the number of times women discussed having obtained information from 
each information source. Table 5 shows the number of times women discussed that they would 
prefer to consult each information source. On 66 (49%) instances young women discussed 
sources from which they obtained HPV-related information and on 68 (51%) instances sources 
from which they would prefer to obtain such information. Participants most often reported 
having received information from the media, family/friends, and health professionals. 
Interestingly, in the Spanish focus groups the most frequent source was family/friends. In the 
Serbian discussions women mentioned obtaining information from few sources overall. The most 
preferred source across all countries was health professionals, followed by searching on the 
Internet. The third category, surprisingly, was family or friends who are also health 
professionals, prominent in the Serbian focus groups. It is noteworthy that scientific sources 
emerged as a preferred category that participants would consult in three out of four countries. 
Discussion 
The goal of this paper was to explore the experiences of young women aged 18-26 with 
communication about the HPV vaccine. This included information and information sources 
about HPV and the HPV vaccine. Being well-informed about the risks and benefits associated 
with HPV and the vaccine is not only ethically desirable but also the first step towards vaccine 
uptake, as several health-behaviour models suggest [29, 42]. Qualitative, cross-cultural 
methodology allowed us to examine in depth the interplay between micro (individual) and macro 
level (societal) factors related to obtaining information about HPV [42]. Our participants were 
university educated women from four European countries with different vaccine implementation 
policies. This age group is especially interesting for two reasons. First, most vaccination policies 
focus on younger girls (11 to 14 years) and populations beyond this age are not eligible for mass 
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immunization. However, older girls and young women could still benefit from vaccination [12]. 
Second, this specific age group (18 to 26 years) offered insight into a variety of experiences. 
These included women who were vaccinated at an earlier age in a school vaccination program 
(Scotland) or via on-demand provision (Spain). Alongside this were women who had relatively 
less exposure to HPV campaigns (Bulgaria) or almost none (Serbia) [9]. Hence, a variety of 
social contexts (e.g., presence of a vaccination program), personal experiences (with information 
and vaccination), and opinions (pro, against or undecided) were represented in the discussions.  
We identified several similar issues in women’s discussions, which we grouped into two 
common themes. The first theme concerned Critical Appraisal of the available information. 
This referred to both the perceived quantity (sufficient or not) and quality evaluations 
(transparent or biased) of information. Overall, women perceived that they did not have 
sufficient knowledge to make an informed decision. Significantly, even women from countries 
where the HPV vaccine had received more state and media attention felt uninformed regarding 
essential aspects of the HPV vaccine. Problems with accessing information were particularly 
striking in Serbia, where the majority of women had no previous information about the vaccine 
(Table 1). Although we cannot conclude that our sample is representative of the general 
population, this finding reflects the state of HPV vaccine implementation in Serbia, where 
vaccination has never been officially recommended and initial campaigns have ceased [9]. In 
fact, this is the first study to our knowledge to address psychological issues related to HPV in 
any population in Serbia.  
Although we did not assess women’s knowledge per se but rather focused on their 
perception of the degree to which they were informed, we should note that there were common 
VIEWS OF YOUNG WOMEN ON HPV VACCINE COMMUNICATION                         28 
 
misconceptions, doubts, and questions about the vaccine. These often related to the relationship 
between sexual activity and the vaccine’s efficacy, the degree of risk reduction provided by the 
vaccine, and the necessity and benefits of screening in combination with vaccination. It might be 
useful in subsequent research to focus on identifying such questions, so that they can be properly 
addressed in information materials. 
Our analysis of information sources revealed that information about HPV reached young 
women mainly through the common channels of social transmission (e.g., family and friends), 
advertisement, and health professionals. However, both the frequency and thematic analyses 
highlight differences between actual experience and preference for information sources. The 
most preferred information source was a health professional. This was, however, followed by an 
Internet search, which often included skimming through “everything that is out there” and 
selecting reliable information. This again highlights women’s preference for self-reliance and the 
ability to critically examine information. However, it is not clear how well young women can 
actually identify high quality information on the Internet, or to what degree low quality 
information influences their decisions. Both the thematic and frequency analysis suggest the 
potential benefit of directing young women to neutral and credible sources where they can 
inform themselves in more detail. Future research should investigate what these sources could be 
depending on the context and how such a strategy influences decision making about the vaccine. 
For example, an international source provided by authorities perceived as trustworthy (e.g., on a 
European rather than national level) may be more effective in increasing trust in information. 
This may be particularly relevant in Eastern Europe where information provided on a local level 
might be met with scepticism. One potentially useful source in our opinion is the webpage of the 
European Cervical Cancer Association (http://www.ecca.info/) which offers the same essential 
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information in different languages.  Future research can also investigate whether presenting the 
information about the vaccine using different information formats might improve risk 
comprehension and risk communication [43, 44].  
Overall women in our sample were critical rather than naïve towards the information they 
encountered. Participants actively searched for information and preferred transparency: to them 
this meant presenting all facts (both pros and cons) in an unbiased fashion so that one could 
make an informed decision. In order to assess the transparency of information, young women 
considered two types of cues: the information provider’s motives (are they genuinely interested 
in my well-being or are they trying to make money?) and the presence of both positive and 
negative information (both benefits and side-effects). Previous qualitative studies with young 
women focused mainly on identifying barriers and facilitators of vaccine acceptance (e.g., [28, 
45]). Our thematic analysis with a focus on the HPV vaccine communication strategy revealed 
that common facilitators of vaccination like health provider recommendation occur within a 
context and could easily misfire if information is not perceived as transparent. Further, this can 
vary not only from person to person but also between contexts. Previous vaccination scares in the 
UK [46] for example, or the complex socio-cultural implications of a communist legacy in some 
Eastern European countries [30] can influence vaccination efforts. Furthermore, people might 
become mistrustful of health-care in general or be especially sensitive to trustworthiness cues in 
health information. A very striking example is the recent HPV campaign failure in post-
communist Romania, where mistrust and conspiracy theories appeared to be the main reason that 
vaccination coverage did not go over 2.5% [29]. Such occurrences suggest that vaccine 
communication can be more effective if culturally-sensitive issues are anticipated and addressed. 
Furthermore, it might be useful to further explore culturally defined notions of information 
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transparency. While our analysis revealed that young women had common notions of 
transparency, transparency as a concept may be subjective. What is regarded as transparent 
information might constitute culturally-specific dimensions (for example, including information 
about particular aspects of a vaccination program might be perceived as more essential in some 
contexts than in others). How transparency is defined in different contexts requires further 
qualitative study. 
Another noteworthy result was related to the commercial side of the vaccine. The image 
of the HPV vaccine as a commercial product sold on the market was seen as inappropriate and 
provoked negativity. The vaccine was regarded as a potentially life-saving product, to which 
everyone should have access. The high costs of this “product” contrasted with the healthcare 
systems of the European countries where the discussions took place, where primary care is free 
or insurance is relatively affordable. Further, this negative view of commercialism might not be 
restricted only to potential recipients of the vaccine. For instance, Bulgarian medical 
professionals expressed similar scepticism about the effectiveness of the vaccine and the profit 
behind it [47].  
The second main theme was Risk Adjustment. It captured how the known risks and 
benefits were adjusted in view of personal (e.g., prospective sexual relations) and societal factors 
(e.g., availability of screening services). Mainly, the risk of contracting HPV was related to the 
number of partners. This led some women to conclude that a single or long term partner meant 
reduced risk. A similar finding with US participants was reported by Hopfer and Clippard [45]: 
“Responses reflected the false belief, in many cases, that monogamy was protective” (p. 272). 
Our analysis, however, suggests that young women carefully considered the risks and benefits 
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their own situation entailed. Rather than feeling absolutely protected by monogamy, participants 
compared their risk of contracting HPV from the present to the risk of someone who would be 
exposed to more partners. In that sense, the vaccine offered less benefit to them at this age and 
this benefit had to compete with the numerous vaccination costs. These costs included the 
monetary cost as well as the psychological costs related to informing oneself properly and 
running additional risks associated with side effects.  
There were some notable differences between countries in discussing alternatives and 
potential uncertainties related to vaccination. Regular screening as an alternative to vaccination 
was more widely discussed in Scotland and Spain, while educating the public about health-
protective behaviours and STIs in general was more prominent in the Bulgarian and Serbian 
discussions. Further, issues about vaccine novelty, media stories about dangerous vaccine side 
effects or rumours about people experiencing them were present in the two Western discussions  
but not in the discussions from the Eastern European countries. These differences might be 
rooted in the nature and degree of information exposure in these countries. This was supported 
by the frequency analysis of information sources, showing that the media and social transmission 
were more common ways to receive information among Scottish and Spanish participants 
surpassing health professionals. Further, Scotland and Spain have already witnessed HPV 
vaccination campaigns. Hence, it is to be expected that young women would be  more aware of 
HPV and screening overall, while the participants from Eastern Europe attributed the absence of 
information to lack of education and support by the state. Similarly, the media in Scotland and 
Spain were more likely to reflect on potential HPV vaccination scares, while HPV was less 
reported in the Bulgarian and Serbian media at the time because of the absence of national 
policies. In that sense, some issues related to vaccine resistance might not only be specific to 
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cultural context but specific to implementation stage. If this is the case, it might be strategic for 
authorities to anticipate and counteract exaggerated vaccine resistance with appropriate risk 
communication. Shortly after this research project was finalized the Bulgarian Ministry of Health 
adopted a vaccination program targeting teenage girls [9]. It will be interesting to see if as 
implementation progresses, similar issues to those in Scotland and Spain arise in Bulgarian 
discussion about HPV.  
Overall our results emphasized the multifaceted role of information acquisition and 
evaluation in vaccination decision making. This is supported by the Information-Motivation-
Behavioral Skills Model (IMB) [42]. The IMB model goes beyond traditional motivational 
models and incorporates the role of vaccine-related information, along motivation and 
behavioural skills in vaccine uptake. Applied to the context of HPV vaccination, the model states 
that individuals who are well-informed, motivated to act, and possess the relevant behavioural 
skills are likely to get vaccinated. The IMB model also incorporates the influence of macro-level 
factors like ethnicity or vaccine cost. Within the framework of the IMB model, our research 
focused on the role of HPV vaccine information and explored its interplay with such macro-level 
factors (e.g., media coverage, socio-cultural context, and trust in authorities). The IMB model 
can be further adapted to accommodate these and other relevant macro-level factors identified by 
qualitative inquiry and examine their influence on individual decision making in a quantitative 
paradigm. The IMB model also emphasizes that skills such as securing funding or negotiating 
health care provider support are essential for vaccine uptake. Our analysis shows that women 
utilize similar skills even at the earlier pre-decision stage of information acquisition as captured 
by the theme Critical Appraisal. These might include the ability to search for information and 
to evaluate the credibility of information sources.  
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There are a few typical limitations and strengths inherent to this type of methodology that 
should be noted. First, we relied on volunteers to participate in the discussions, which might have 
attracted participants with a strong opinion about the HPV vaccine. However, the fact that there 
were participants who had no prior information about the HPV vaccine in all countries but 
Scotland speaks against this possibility. Second, some original meanings might have been lost 
after translating the transcripts into English. In order to minimize this problem, we involved 
native speakers in the analysis, used multiple coders, and chose an analytical procedure which is 
not highly sensitive to language use [40]. On the other hand, one major advantage of qualitative 
methods is that participants’ answers are less constrained by the researcher’s perspective. This 
provides the opportunity to discover in depth issues important to participants that might not have 
occurred to researchers (e.g., [48]) and to consider participants’ reflections in their broader socio-
cultural context. 
Conclusion 
HPV is the most frequent sexually-transmitted infection worldwide and a cause of 
cervical cancer [3]. The HPV vaccine is potentially one way to reduce cervical cancer incidence 
but questions and challenges to implementation remain [21]. Informing the public is an essential 
and ethically desirable step to prevention. However, recent analyses in Europe [22], the US [49], 
and Canada [24] reveal that information about HPV might be suboptimal and inaccurate even 
when provided by official authorities. It is not yet clear how the public deals with such 
information. Our qualitative, thematic analysis demonstrated that the 54 young university 
educated women who participated in our discussions took most information about the HPV 
vaccine with a grain of salt: They evaluated the quality of information and preferred transparent 
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to selective or biased reporting. This suggests that it would be beneficial to direct young women 
to credible, high-quality information sources they can consult on their own or encourage 
consultation with a health professional, who was still regarded as the most preferred information 
source. However, the question remains as to how less privileged groups deal with information. In 
addition, young women considered the decision to vaccinate against HPV at their age (18 to 26 
years) as highly individualized; they considered their lifestyle and potential alternatives to 
vaccination; they also recognized the uncertainty related to making a decision in view of 
(un)regulated communication of evidence and uncertainty inherent with new vaccines. Last, the 
cultural context influenced women’s exposure to information and shaped their perceptions of 
vaccine relevance and safety. 
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